Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe.

Makadzange AT, Higgins-Biddle M, Chimukangara B, Birri R, Gordon M, Mahlanza T, McHugh G, van Dijk JH, Bwakura-Dangarembizi M, Ndung'u T, Masimirembwa C, Phelps B, Amzel A, Ojikutu BO, Walker BD, Ndhlovu CE.

PLoS One. 2015 Dec 14;10(12):e0144057. doi: 10.1371/journal.pone.0144057. eCollection 2015.

2.

Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.

Bure D, Makhdoomi MA, Lodha R, Prakash SS, Kumar R, Parray HA, Singh R, Kabra SK, Luthra K.

Viruses. 2015 Feb 10;7(2):590-603. doi: 10.3390/v7020590.

3.

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, van de Wijgert J, Asiimwe A, Reiss P, Geelen SP.

PLoS One. 2014 Nov 3;9(11):e111948. doi: 10.1371/journal.pone.0111948. eCollection 2014.

4.

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.

5.

Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China.

Zheng J, Zhao D.

BMC Res Notes. 2014 Jul 3;7:419. doi: 10.1186/1756-0500-7-419.

6.

Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.

Collins IJ, Judd A, Gibb DM.

Curr Opin HIV AIDS. 2014 Jan;9(1):87-94. doi: 10.1097/COH.0000000000000027. Review.

7.

Immunology of pediatric HIV infection.

Tobin NH, Aldrovandi GM.

Immunol Rev. 2013 Jul;254(1):143-69. doi: 10.1111/imr.12074. Review.

8.

Effect of antiretroviral therapy on clinical and immunologic disease progression in HIV positive children: One-year follow-up study.

Patel A, Trivedi SS, Chudasama RK, Patel PK.

J Family Community Med. 2012 Sep;19(3):178-83. doi: 10.4103/2230-8229.102318.

9.

Mortality and treatment outcomes of China's National Pediatric antiretroviral therapy program.

Zhao Y, Li C, Sun X, Mu W, McGoogan JM, He Y, Cheng Y, Tang Z, Li H, Ni M, Ma Y, Chen RY, Liu Z, Zhang F.

Clin Infect Dis. 2013 Mar;56(5):735-44. doi: 10.1093/cid/cis941. Epub 2012 Nov 21.

10.

Successful clinical outcomes following decentralization of tertiary paediatric HIV care to a community-based paediatric antiretroviral treatment network, Chiangrai, Thailand, 2002 to 2008.

Hansudewechakul R, Naiwatanakul T, Katana A, Faikratok W, Lolekha R, Thainuea V, McConnell MS.

J Int AIDS Soc. 2012 Oct 11;15(2):17358. doi: 10.7448/IAS.15.2.17358.

11.

Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana.

Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E.

AIDS Res Treat. 2011;2011:896040. doi: 10.1155/2011/896040. Epub 2011 May 11.

12.

Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.

Van Dyke RB, Patel K, Siberry GK, Burchett SK, Spector SA, Chernoff MC, Read JS, Mofenson LM, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study.

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):165-73. doi: 10.1097/QAI.0b013e318215c7b1.

13.

Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries.

Peacock-Villada E, Richardson BA, John-Stewart GC.

Pediatrics. 2011 Feb;127(2):e423-41. doi: 10.1542/peds.2009-2701. Epub 2011 Jan 24. Review.

14.

Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database.

Hansudewechakul R, Sirisanthana V, Kurniati N, Puthanakit T, Lumbiganon P, Saphonn V, Yusoff NK, Kumarasamy N, Fong SM, Nallusamy R, Srasuebkul P, Law M, Sohn AH, Chokephaibulkit K; TREAT Asia Pediatric HIV Observational Database.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):503-9. doi: 10.1097/QAI.0b013e3181f5379a.

15.

Adolescent HIV--cause for concern in Southern Africa.

Gray GE.

PLoS Med. 2010 Feb 2;7(2):e1000227. doi: 10.1371/journal.pmed.1000227. No abstract available.

16.

Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.

Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, Mujuru H, Ndhlovu CE, Munyati S, Cowan FM, Gibb DM, Corbett EL.

PLoS Med. 2010 Feb 2;7(2):e1000178. doi: 10.1371/journal.pmed.1000178.

17.

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Levin MJ, Anderson JP, Seage GR 3rd, Williams PL; PACTG/IMPAACT 219C Team.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):182-91. doi: 10.1097/QAI.0b013e31819550a4.

18.

Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Jun 1;46(11):1751-60. doi: 10.1086/587900.

19.

Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.

Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, Overbaugh J, Emery S, Wariua G, Gichuhi C, Bosire R, John-Stewart G.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):311-7.

20.

Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells.

Roucairol C, Azoulay S, Nevers MC, Créminon C, Lavrut T, Garraffo R, Grassi J, Burger A, Duval D.

Antimicrob Agents Chemother. 2007 Feb;51(2):405-11. Epub 2006 Nov 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk